Not applicableStudy completedNCT01159743
What this trial is testing
A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine
Who this might be right for
HIV Infection
AbbVie (prior sponsor, Abbott) 346